Telehealth Red Flags
Nine concrete warning signs that an online telehealth provider may not be safe or legitimate — each verifiable before you pay.
What are the biggest telehealth red flags?
The biggest telehealth red flags are: no medical review before prescribing, unclear state licensure, no pharmacy disclosure, claims that compounded medication is “FDA-approved,” marketing that calls compounded products “generic Ozempic” or “generic Zepbound,” missing refund/cancellation policies, unrealistic weight-loss promises, hidden fees, and no support after checkout. Any one of these warrants caution.
Disclaimer: American Telehealth Review is an editorial resource and does not provide medical advice, diagnosis, or treatment. Compounded medications are not FDA-approved finished drug products and should only be prescribed when clinically appropriate by a licensed healthcare provider. Brand-name medications such as Ozempic, Wegovy, Mounjaro, and Zepbound are FDA-approved under their own applications. Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products.
The 9 red flags
- No medical review before prescribing
- No clarity on state licensure
- No pharmacy disclosure
- Claims of “FDA-approved compounded” medication
- Claims of “generic Ozempic” or “generic Zepbound”
- No refund or cancellation policy
- Unrealistic weight-loss promises
- Hidden subscription or dose-based fees
- No support after checkout
Why these matter
Each red flag maps to a real risk — unsupervised prescribing, unverifiable sourcing, deceptive marketing, or hidden cost. The “generic Ozempic” framing is especially misleading. Brand-name medications such as Ozempic, Wegovy, Mounjaro, and Zepbound are FDA-approved under their own applications. Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products.
How to check before paying
Run the 8-point evaluation checklist, verify the pharmacy via our transparency guide, and sanity-check pricing against the independent price index so a low teaser rate doesn't hide a high maintenance cost.
Illustrative 12-month cost: flat-rate vs dose-tiered
| Pricing model | How it behaves | Illustrative 12-month cost |
|---|---|---|
| Flat-rate | Same price at every dose | ~$1,740 |
| Dose-tiered | Rises as the dose is titrated up | ~$2,400–$3,000 |
Confirm the actual maintenance-dose, all-in monthly price with any provider; see an independent price index for current figures.
Frequently asked questions
How do I know if a telehealth provider is a scam?
Watch for the nine red flags — especially no medical review, no pharmacy disclosure, and “FDA-approved compounded” or “generic Ozempic” claims.
Is “generic Ozempic” real?
No. There is no generic Ozempic. Brand-name medications such as Ozempic, Wegovy, Mounjaro, and Zepbound are FDA-approved under their own applications. Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products.
Are hidden dose-based fees common?
Some providers raise prices as your dose increases; confirm the maintenance-dose price before enrolling.
Sources
- U.S. FDA — Medications containing semaglutide and tirzepatide (fda.gov).
- U.S. Food & Drug Administration — Compounding and the FDA (fda.gov).
- Federation of State Medical Boards — Telemedicine policy resources (fsmb.org).